✦ LIBER ✦

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder

✍ Scribed by Etsuya Watanabe; Hideyasu Matsuyama; Kenji Matsuda; Chietaka Ohmi; Yasuhide Tei; Satoru Yoshihiro; Yasukazu Ohmoto; Katsusuke Naito

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 211 KB
Volume: 52
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-003-0384-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of urinary interleukin-1 (IL-1

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

✍ E. C. De Boer; W. H. De Jong; P. A. Steerenberg; L. A. Aarden; E. Tetteroo; E. R 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 833 KB

Reactive antibodies against bacillus Cal

Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder

✍ Peter U. Ardelt; Burkhard Kneitz; Patrick Adam; Cora Reiss; Arkadius Kocot; Joac 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB 👁 1 views

Prospective phase II trial of alternatin

Prospective phase II trial of alternating intravesical Bacillus Calmette-Guérin (BCG) and Interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: Preliminary results

✍ S. Bazarbashi; M.A. Raja; A. El Sayed; A. Ezzat; E. Ibrahim; S. Kattan; A. Karda 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views